Bone imaging in metastatic breast cancer

Journal of Clinical Oncology

Volumn 22, Issue 14, 2004, Pages 2942-2953

  Hamaoka, Tsuyoshi ^a   Madewell, John E ^a   Podoloff, Donald A ^a   Hortobagyi, Gabriel N ^a   Ueno, Naoto T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE METABOLISM; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; BREAST CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; PRIORITY JOURNAL; RADIOLOGIST; ALGORITHM; BONE TUMOR; BREAST TUMOR; DIAGNOSTIC IMAGING; FEMALE; METASTASIS; PATHOLOGY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALGORITHMS; BONE NEOPLASMS; BREAST NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4344569455     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.08.181     Document Type: Article

References (100)

1. Galasko CS: Skeletal metastases and mammary cancer. Ann R Coll Surg Engl 50:3-28, 1972
2. Schurman DJ, Amstutz HC: Orthopedic management of patients with metastatic carcinoma of the breast. Surg Gynecol Obstet 137:831-836, 1973
3. Cadman E, Bertino JR: Chemotherapy of skeletal metastases. Int J Radiat Oncol Biol Phys 1:1211-1215, 1976
4. Hoogstraten B, Gad-el-Mawla N, Maloney TR, et al: Combined modality therapy for first recurrence of breast cancer: A Southwest Oncology Group study. Cancer 54:2248-2256, 1984
5. Scheid V, Buzdar AU, Smith TL, et al: Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy. Cancer 58:2589-2593, 1986
6. Coleman RE, Rubens RD: The clinical course of bone metastases from breast cancer. Br J Cancer 55:61-66, 1987
7. Hortobagyi GN: Bone metastases in breast cancer patients. Semin Oncol 18:11-15, 1991
8. Solomayer EF, Diel IJ, Meyberg GC, et al: Metastatic breast cancer: Clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59:271-278, 2000
9. Hortobagyi GN: Unmet needs in metastatic bone disease and its complications: Is progress possible? Semin Oncol 28:1-3, 2001
10. Lipton A: Bisphosphonates and metastatic breast carcinoma. Cancer 97:848-853, 2003
11. Fisher B, Ravdin RG, Ausman RK, et al: Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation. Ann Surg 168:337-356, 1968
12. Libshitz HI, Hortobagyi GN: Radiographic evaluation of therapeutic response in bony metastases of breast cancer. Skeletal Radiol 7:159-165, 1981
13. Pivot X, Asmar L, Hortobagyi GN, et al: A retrospective study of first indicators of breast cancer recurrence. Oncology 58:185-190, 2000
14. Hortobagyi GN: Novel approaches to the management of bone metastases in patients with breast cancer. Semin Oncol 29:134-144, 2002
15. Rubens RD: Bone metastases-the clinical problem. Eur J Cancer 34:210-213, 1998
16. Hortobagyi GN, Theriault RL, Lipton A, et al: Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate: Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol 16:2038-2044, 1998
17. Roodman GD: Biology of osteoclast activation in cancer. J Clin Oncol 19:3562-3571, 2001
18. Theriault RL, Lipton A, Hortobagyi GN, et al: Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomized, placebo- controlled trial: Protocol 18 Aredia Breast Cancer Study Group. J Clin Oncol 17:846-854, 1999
19. Coleman RE: Management of bone metastases. Oncologist 5:463-470, 2000
20. LoRusso P: Analysis of skeletal-related events in breast cancer and response to therapy. Semin Oncol 28:22-27, 2001
21. Janjan N: Bone metastases: Approaches to management. Semin Oncol 28:28-34, 2001
22. Hayward JL, Carbone PP, Heusen JC, et al: Assessment of response to therapy in advanced breast cancer. Br J Cancer 35:292-298, 1977
23. Hayward JL, Carbone PP, Rubens RD, et al: Assessment of response to therapy in advanced breast cancer (an amendment). Br J Cancer 38:201, 1978
24. WHO handbook for reporting results of cancer treatment. Geneva (Switzerland), World Health Organization Offset Pulication, 1979
25. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216, 2000
26. National Cancer Institute: Levels of Evidence for Human Studies of Cancer Complementary and Alternative Medicine. Bethesda, MD, National Cancer Institute, 2002. http://www.cancer.gov/cancerinfo/pdq/levels-evidence-cam (accessed December 19, 2003)
27. Vinholes J, Coleman R, Eastell R: Effects of bone metastases on bone metabolism: Implications for diagnosis, imaging and assessment of response to cancer treatment. Cancer Treat Rev 22:289-331, 1996
28. Theriault RL, Hortobagyi GN: Bone metastasis in breast cancer. Anticancer Drugs 3:455-462, 1992
29. Citrin DL: The role of the bone scan in the investigation and treatment of breast cancer. Crit Rev Diagn Imaging 13:39-55, 1980
30. Hortobagyi GN, Libshitz HI, Seabold JE: Osseous metastases of breast cancer. Clinical, biochemical, radiographic, and scintigraphic evaluation of response to therapy. Cancer 53:577-582, 1984
31. Yoneda T, Sasaki A, Mundy GR: Osteolytic bone metastasis in breast cancer. Breast Cancer Res Treat 32:73-84, 1994
32. Mundy GR: Mechanisms of bone metastasis. Cancer 80:1546-1556, 1997
33. Tofe AJ, Francis MD, Harvey WJ: Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans. J Nucl Med 16:986-989, 1975
34. Corcoran RJ, Thrall JH, Kyle RW, et al: Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 121:663-667, 1976
35. Krishnamurthy GT, Tubis M, Hiss J, et al: Distribution pattern of metastatic bone disease. A need for total body skeletal image. JAMA 237:2504-2506, 1977
36. Perez DJ, Powles TJ, Milan J, et al: Detection of breast carcinoma metastases in bone: Relative merits of X-rays and skeletal scintigraphy. Lancet 2:613-616, 1983
37. Tubiana-Hulin M: Incidence, prevalence and distribution of bone metastases. Bone 12: S9-S10, 1991 (suppl 1)
38. Baston OV: The function of the vertebral veins and their role in the spread of metastases. Ann Surg 112:138-149, 1940
39. Ellis RE: The distribution of active red marrow in the adult. Phys Med Biol 5:255-258, 1961
40. Russell WJ, Yoshinagah Antoku S, et al: Active bone marrow distribution in the adult. Br J Radiol 39:735-739, 1966
41. Mundy GR, Guise TA, Yoneda T: Biology of bone metastasis, in Harris JR, Lippman ME, Morrow M, et al (eds): Diseases of the breast (ed 2nd). Philadelphia, Lippincott Williams & Wilkins, 2000, pp 911-919
42. Savelli G, Maffioli L, Maccauro M, et al: Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions. Q J Nucl Med 45:27-37, 2001
43. Wickerham L, Fisher B, Cronin W: The efficacy of bone scanning in the follow-up of patients with operable breast cancer. Breast Cancer Res Treat 4:303-307, 1984
44. Krasnow AZ, Hellman RS, Timins ME, et al: Diagnostic bone scanning in oncology. Semin Nucl Med 27:107-141, 1997
45. Coleman RE, Rubens RD: Bone metastases and breast cancer. Cancer Treat Rev 12:251-270, 1985
46. Goris ML, Bretille J: Skeletal scintigraphy for the diagnosis of malignant metastatic disease to the bones. Radiother Oncol 3:319-329, 1985
47. Petren-Mallmin M, Andreasson I, Nyman R, et al: Detection of breast cancer metastases in the cervical spine. Acta Radiol 34:543-548, 1993
48. Sanders TG, Parsons TW 3rd: Radiographic imaging of musculoskeletal neoplasia. Cancer Control 8:221-231, 2001
49. Galasko CS, Doyle FH: The response to therapy of skeletal metastases from mammary cancer: Assessment by scintigraphy. Br J Surg 59:85-88, 1972
50. Tryciecky EW, Gottschalk A, Ludema K: Oncologic imaging: Interactions of nuclear medicine with CT and MRI using the bone scan as a model. Semin Nucl Med 27:142-151, 1997
51. Coleman RE: Monitoring of bone metastases. Eur J Cancer 34:252-259, 1998
52. Cook GJ, Fogelman I: The role of positron emission tomography in the management of bone metastases. Cancer 88:2927-2933, 2000
53. Rybak LD, Rosenthal DI: Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med 45:53-64, 2001
54. Hopkins GB, Kristensen KA, Blickenstaff DE: Fluorine 18 bone scans in the detection of early metastatic bone tumors. JAMA 222:813-814, 1972
55. Galasko CS: The value of scintigraphy in malignant disease. Cancer Treat Rev 2:225-272, 1975
56. O'Mara RE: Skeletal scanning in neoplastic disease. Cancer 37:480-486, 1976
57. Pauwels EK, Stokkel MP: Radiopharmaceuticals for bone lesions. Imaging and therapy in clinical practice. Q J Nucl Med 45:18-26, 2001
58. Subramanian G, McAfee JG: A new complex of 99mTc for skeletal imaging. Radiology 99:192-196, 1971
59. Citrin DL, Bessent RG, Greig WR: A comparison of the sensitivity and accuracy of the 99TCm-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol 28:107-117, 1977
60. Citrin DL, Tormey DC, Carbone PP: Implications of the 99mTc diphosphonate bone scan on treatment of primary breast cancer. Cancer Treat Rep 61:1249-1252, 1977
61. Haubold-Reuter BG, Duewell S, Schilcher BR, et al: The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: A prospective study. Eur J Nucl Med 20:1063-1069, 1993
62. Citrin DL, Furnival CM, Bessent RG, et al: Radioactive technetium phosphate bone scanning in preoperative assessment and follow-up study of patients with primary cancer of the breast. Surg Gynecol Obstet 143:360-364, 1976
63. Daffner RH, Lupetin AR, Dash N, et al: MRI in the detection of malignant infiltration of bone marrow. AJR Am J Roentgenol 146:353-358, 1986
64. Crippa F, Seregni E, Agresti R, et al: Bone scintigraphy in breast cancer: A ten-year follow-up study. J Nucl Biol Med 37:57-61, 1993
65. Gosfield E 3rd, Alavi A, Kneeland B: Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases. J Nucl Med 34:2191-2198, 1993
66. Flickinger FW, Sanal SM: Bone marrow MRI: Techniques and accuracy for detecting breast cancer metastases. Magn Reson Imaging 12:829-835, 1994
67. Kosuda S, Kaji T, Yokoyama H, et al: Does bone SPECT actually have lower sensitivity for detecting vertebral metastasis than MRI? J Nucl Med 37:975-978, 1996
68. Eustace S, Tello R, DeCarvalho V, et al: A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169:1655-1661, 1997
69. Han LJ, Au-Yong TK, Tong WC, et al: Comparison of bone single-photon emission tomography and planar imaging in the detection of vertebral metastases in patients with back pain. Eur J Nucl Med 25:635-638, 1998
70. Ohta M, Tokuda Y, Suzuki Y, et al: Whole body PET for the evaluation of bony metastases in patients with breast cancer: Comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun 22:875-879, 2001
71. Daldrup-Link HE, Franzius C, Link TM, et al: Whole-body MR imaging for detection of bone metastases in children and young adults: Comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 177:229-236, 2001
72. Kido DK, Gould R, Taati F, et al: Comparative sensitivity of CT scans, radiographs and radionuclide bone scans in detecting metastatic calvarial lesions. Radiology 128:371-375, 1978
73. Rosenthal DI: Radiologic diagnosis of bone metastases. Cancer 80:1595-1607, 1997
74. Yang SN, Liang JA, Lin FJ, et al: Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer. J Cancer Res Clin Oncol 128:325-328, 2002
75. Galasko CS, Doyle FH: The detection of skeletal metastases from mammary cancer: A regional comparison between radiology and scintigraphy. Clin Radiol 23:295-297, 1972
76. Lee YT: Bone scanning in patients with early breast carcinoma: Should it be a routine staging procedure? Cancer 47:486-495, 1981
77. Coleman RE, Rubens RD, Fogelman I: Reappraisal of the baseline bone scan in breast cancer. J Nucl Med 29:1045-1049, 1988
78. Dershaw DD, Osborne M: Imaging techniques in breast cancer. Semin Surg Oncol 5:82-93, 1989
79. Loeffler RK, DiSimone RN, Howland WJ: Limitations of bone scanning in clinical oncology. JAMA 234:1228-1232, 1975
80. Condon BR, Buchanan R, Garvie NW, et al: Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging. Br J Radiol 54:18-23, 1981
81. Arnstein NB, Harbert JC, Byrne PJ: Efficacy of bone and liver scanning in breast cancer patients treated with adjuvant chemotherapy. Cancer 54:2243-2247, 1984
82. Holder LE: Clinical radionuclide bone imaging. Radiology 176:607-614, 1990
83. The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: A multicenter randomized controlled trial. JAMA 271:1587-1592, 1994
84. Beahrs OH: Staging of cancer of the breast as a guide to therapy. Cancer 53:592-594, 1984
85. Pedrazzini A, Gelber R, Isley M, et al: First repeated bone scan in the observation of patients with operable breast cancer. J Clin Oncol 4:389-394, 1986
86. Coleman RE, Fogelman I, Habibollahi F, et al: Selection of patients with breast cancer for routine follow-up bone scans. Clin Oncol (R Coll Radiol) 2:328-332, 1990
87. Kunkler IH, Merrick MV, Rodger A: Bone scintigraphy in breast cancer: A nine-year follow-up. Clin Radiol 36:279-282, 1985
88. Khansur T, Haick A, Patel B, et al: Evaluation of bone scan as a screening work-up in primary and local-regional recurrence of breast cancer. Am J Clin Oncol 10:167-170, 1987
89. Brar HS, Sisley JF, Johnson RH Jr: Value of preoperative bone and liver scans and alkaline phosphatase in the evaluation of breast cancer patients. Am J Surg 165:221-223, 1993
90. Yen KA, Fortunato L, Ridge JA, et al: Routine bone scanning in patients with T1 and T2 breast cancer: A waste of money. Ann Surg Oncol 2:319-324, 1995
91. Samant R, Ganguly P: Staging investigations in patients with breast cancer: The role of bone scans and liver imaging. Arch Surg 134:551-553, 1999
92. Koizumi M, Yoshimoto M, Kasumi F, et al: What do breast cancer patients benefit from staging bone scintigraphy? Jpn J Clin Oncol 31:263-269, 2001
93. Rosselli Del Turco M, Palli D, Cariddi A, et al: Intensive diagnostic follow-up after treatment of primary breast cancer: A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 271:1593-1597, 1994
94. Komaki R, Donegan W, Manoli R, et al: Prognostic value of pretreatment bone scans in breast carcinoma. AJR Am J Roentgenol 132:877-881, 1979
95. Tomin R, Donegan WL: Screening for recurrent breast cancer: Its effectiveness and prognostic value. J Clin Oncol 5:62-67, 1987
96. Zwaveling A, Albers GH, Felthuis W, et al: An evaluation of routine follow-up for detection of breast cancer recurrences. J Surg Oncol 34:194-197, 1987
97. Stierer M, Rosen HR: Influence of early diagnosis on prognosis of recurrent breast cancer. Cancer 64:1128-1131, 1989
98. Smith TJ, Davidson NE, Schapira DV, et al: American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17:1080-1082, 1999
99. Janicek MJ, Shaffer K: Scintigraphic and radiographic patterns of skeletal metastases in breast cancer: Value of sequential imaging in predicting outcome. Skeletal Radiol 24:597-600, 1995
100. Greenburg EJ, Chu FC, Dwyer AJ, et al: Effects of radiation therapy on bone lesions as measured by 47 Ca and 85 Sr local kinetics. J Nucl Med 13:747-751, 1972